Dual Targeting Strategy Enhances Immunotherapy Effectiveness in Glioblastoma
Glioblastoma (GBM), recognized as one of the most aggressive and fatal brain cancers, continues to present formidable challenges for effective treatment. Despite advancements in medical...
















